Study to Evaluate Safety, Tolerability, PK and PD of ALXN1007 in Healthy Subjects
Clinical trial NCT01454986 · COMPLETED
Trial details
- NCT number
- NCT01454986
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-08-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.